Robert Thomas Dechant, an officer and director of IBEX Ltd, filed a Form 144 notice on November 9, 2026, proposing the sale of 5,000 shares of IBEX Ltd common stock through RBC Capital Markets LLC on NASDAQ.

Key Highlights

  • Proposed sale: 5,000 shares of IBEX Ltd common stock, with an aggregate market value of $250,031.00, according to the filing.
  • Seller: Robert Thomas Dechant, identified in the filing as both an officer and a director of IBEX Ltd.
  • Shares outstanding: The filing lists 13,333,839 shares of common stock outstanding.
  • Source of shares: The 5,000 shares were acquired via an RSA vest from the issuer on December 28, 2018.
  • Prior sale: Dechant sold 5,000 shares of IBEX Ltd common stock on September 25, 2026, for gross proceeds of $225,095.00, according to the filing.
  • 10b5-1 plan: The filing states the sale is "sold pursuant to a Rule 10b5-1 plan established 11/18/2025."
  • Approximate sale date: November 9, 2026, through broker RBC Capital Markets LLC on NASDAQ.

Dechant's Proposed Sale Details and Plan Background

According to the Form 144 notice filed with the SEC, Robert Thomas Dechant, serving as both an officer and director of IBEX Ltd (NASDAQ:IBEX), proposes to sell 5,000 shares of the company's common stock. The filing lists the aggregate market value of the proposed sale at $250,031.00. The broker named for the transaction is RBC Capital Markets LLC, located at 250 Nicollet Mall, Suite 1700, Minneapolis, MN 55401, with the sale expected to occur on NASDAQ.

The filing discloses that the 5,000 shares subject to the proposed sale were acquired on December 28, 2018, through an RSA vest from the issuer, with payment described as "N/A." The notice was signed by POA Jeff Kapala on Dechant's behalf. The filing notes that the transaction is being conducted pursuant to a Rule 10b5-1 trading plan that was adopted on November 18, 2025, with the plan adoption date cited in the filing as the relevant representation date.

In the section covering securities sold during the past three months, the filing reports that Dechant sold 5,000 shares of IBEX Ltd common stock on September 25, 2026, generating gross proceeds of $225,095.00, also through RBC Capital Markets LLC. The total shares of common stock outstanding are listed in the filing as 13,333,839.

What Was Disclosed

IBEX Ltd officer and director Robert Thomas Dechant filed a Form 144 notice proposing to sell 5,000 common shares with an aggregate market value of $250,031.00, under a Rule 10b5-1 plan established November 18, 2025, through RBC Capital Markets LLC on NASDAQ.